Tango Therapeutics (TNGX) delivered earnings and revenue surprises of 20.59% and 44.35%, respectively, for the quarter ended September 2024. Do the...
Vous n'êtes pas connecté
Sangamo (SGMO) delivered earnings and revenue surprises of 233.33% and 86.11%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Tango Therapeutics (TNGX) delivered earnings and revenue surprises of 20.59% and 44.35%, respectively, for the quarter ended September 2024. Do the...
Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of 64.44% and 95%, respectively, for the quarter ended September 2024. Do the...
Fate Therapeutics (FATE) delivered earnings and revenue surprises of 4.76% and 249.32%, respectively, for the quarter ended September 2024. Do the...
Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of 25% and 5.68%, respectively, for the quarter ended September 2024. Do the...
Lyra Therapeutics (LYRA) delivered earnings and revenue surprises of 21.74% and 51.25%, respectively, for the quarter ended September 2024. Do the...
Zevra Therapeutics (ZVRA) delivered earnings and revenue surprises of -56.82% and 26.69%, respectively, for the quarter ended September 2024. Do the...
BioXcel Therapeutics (BTAI) delivered earnings and revenue surprises of 36% and 82.17%, respectively, for the quarter ended September 2024. Do the...
Ardmore Shipping (ASC) delivered earnings and revenue surprises of 3.77% and 1.27%, respectively, for the quarter ended September 2024. Do the numbers...
Kinross Gold (KGC) delivered earnings and revenue surprises of 33.33% and 20.67%, respectively, for the quarter ended September 2024. Do the numbers...
Perion Network (PERI) delivered earnings and revenue surprises of 4.55% and 2.28%, respectively, for the quarter ended September 2024. Do the numbers...